Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s footer release/revision label has been updated from v3.5.2 to v3.5.3, indicating a site/version maintenance update rather than a change to the clinical trial study details.
    Difference
    0.0%
    Check dated 2026-04-24T16:46:03.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:59:07.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Added a new Resources entry: Cutaneous neuroendocrine carcinoma with Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-03T05:51:44.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    - Revision labels updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T23:46:46.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T19:49:01.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page shows a minor update: Revision v3.4.2 was added and Revision v3.4.1 was removed. This update affects only metadata and does not alter study content or user-facing functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:31:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.